The core activity of CEBIS is the conduct of clinical trials and the provision of regulatory services for the pharmaceutical industry, biotechnology companies, and manufacturers of medical devices. This includes, among other things: Conduct of clinical trials (Phase II-IV), regulatory support for market authorization, management of clinical trials, creation of regulatory documents (e.g. CTD for medicinal products), conduct of disease registries, and regulatory affairs and compliance services. CEBIS positions itself as a full-service provider for clinical research and regulatory services, offering its customers a comprehensive range of services to support their products from idea to market authorization.